Publicación:
Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis

Vista sencilla de ítem
dc.contributor.authorMolina D, Víctorspa
dc.contributor.authorÁlzate V, Davidspa
dc.contributor.authorRuíz B, Jhonspa
dc.contributor.authorUrrea A, Manuelaspa
dc.contributor.authorTobón J, Juanspa
dc.date.accessioned2014-09-20 00:00:00
dc.date.accessioned2022-06-17T20:08:44Z
dc.date.available2014-09-20 00:00:00
dc.date.available2022-06-17T20:08:44Z
dc.date.issued2014-09-20
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.21897/rmvz.91
dc.identifier.eissn1909-0544
dc.identifier.issn0122-0268
dc.identifier.urihttps://repositorio.unicordoba.edu.co/handle/ucordoba/5303
dc.identifier.urlhttps://doi.org/10.21897/rmvz.91
dc.language.isospaspa
dc.publisherUniversidad de Córdobaspa
dc.relation.bitstreamhttps://revistamvz.unicordoba.edu.co/article/download/91/160
dc.relation.citationeditionNúm. 3 , Año 2014 : Revista MVZ Córdoba Volumen 19(3) Septiembre-Diciembre 2014spa
dc.relation.citationendpage4300
dc.relation.citationissue3spa
dc.relation.citationstartpage4289
dc.relation.citationvolume19spa
dc.relation.ispartofjournalRevista MVZ Córdobaspa
dc.relation.referencesSanderson RO, Beata C, Flipo R-M, Genevois J-P, Macias C, Tacke S, et al. Systematic review of the management of canine osteoarthritis. Vet Rec. 2009;164:418–24. http://dx.doi.org/10.1136/vr.164.14.418spa
dc.relation.referencesInnes FJ, Cayton J, Lascelles BDX. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec. 2010 Feb 20;166(1):226–30. http://dx.doi.org/10.1136/vr.c97spa
dc.relation.referencesLizarraga Madrigal I, Sumano Lopez H, Castillo Alcala F. Cyclooxygenase-2 selective inhibitors: Potential usage in dogs. Vet Mex. 2002;33(3):2–24.spa
dc.relation.referencesJohnston S, M.McLaughlin R, Budsberg SC. Nonsurgical Management of Osteoar thritis in Dogs. Vet Clin Small Anim. 2008;38:1449–70. http://dx.doi.org/10.1016/j.cvsm.2008.08.001spa
dc.relation.referencesAragon CL, Hofmeister EH, Budsberg S. Systematic review of clinical trials of treatments for osteoarthritis in dogs. JAVMA. 2007;230(4):514–21. http://dx.doi.org/10.2460/javma.230.4.514spa
dc.relation.referencesHenderson AK, Webster CLR. Disruption of the Gastric Mucosal Barrier in Dogs [Internet]. CompendiumVet.com. 2006. Available from: http://cp.vetlearn.com/Media/PublicationsArticle/PV_28_05_340.pdfspa
dc.relation.referencesNakagawa K, Yamagami T, Takemura N. Hepatocellular toxicosis associated white the alternate administration of carprofen and meloxicam in a siberian husky. j.vet.med.sci. 2005;67(10):1051–3.spa
dc.relation.referencesBatlouni M. Antiinflamatorios No Esteroides: Efectos Cardiovasculares, Cerebrovasculares y Renales. Arq Bras Cardiol. 2010; 94(4):538-46.spa
dc.relation.referencesAutefage A, Palissier FM, Asimus E, Pepin-Richard C. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis. Vet Rec. 2011;168:617–23. http://dx.doi.org/10.1136/vr.d1456spa
dc.relation.referencesBergh MS, Budsberg S. The coxib NSAIDs: potential clinical and phamacologic importance in veterinary medicine. J Vet Intern Med. 2005;19(1):633–43. http://dx.doi.org/10.1111/j.1939-1676.2005.tb02741.xspa
dc.relation.referencesChoitsu SC, Soen S. Efficacy and Safety of the Selective Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Rheumatoid Arthritis and Osteoarthritis in Japan. Digestion. 2011;83(1):108–23.spa
dc.relation.referencesAnderson A. Treatment of hip dysplasia. J Small Anim Pract. 2011;52:182–9. http://dx.doi.org/10.1111/j.1748-5827.2011.01049.xspa
dc.relation.referencesMichelin A de F, Ferreira Peres AA, Bitar Galvini B, Lopez Cruz L. Toxicidade renal de inhibidores selectivos da cicloxigenasa 2 : celecoxib e rofecoxib. Rev Ciênc Méd Campinas. 2006;4(15):322–32.spa
dc.relation.referencesVásquez-Cotés S, Vásquez-Fuertes L, Rodríguez-Alvárez M, Reig-Rincón de Arellano I, Martínez-Cócera C. Tolerancia a celecoxib y meloxicam en pacientes con intolerancia a analgésicos no esteroides. Med Interna. 2008;25(4):163–7.spa
dc.relation.referencesLuna S, Bastilio A, Steagall P. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen and meloxicam in dogs. Am J Vet Res. 2007;68:258–64. http://dx.doi.org/10.2460/ajvr.68.3.258spa
dc.relation.referencesDoig PA, Purbrick KA, Hare JE, McKeown DB. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis. Can Vet J. 2000;41(1):296–300.spa
dc.relation.referencesTabibian J, Tabibian N, Kaufman D. Late-onset celecoxib induced combined hepato nephrotoxicity. Br J Clin Pharmacol. 2008;66(1):150–2. http://dx.doi.org/10.1111/j.1365-2125.2008.03157.xspa
dc.relation.referencesJoubert KE. The effects of firocoxib (previcox) in geriatric dogs over a period of 90 days. JSAfr.vetASS. 2009;60(3):179–84.spa
dc.relation.referencesRoberts ES, Van Lare KA, Marable BR, Salminen WF. Safety and tolerability of 3 week and 6 moths dosing of Deracoxib (Deramaxx) chewable tablets in dogs. Jvet Paharmacol Ther. 2008;32(329):337.spa
dc.relation.referencesAgustí A, Danés I. Modificación del efecto antiagregante de ácido acetil salicílico por los fármacos antiinflamatorios no esteroideos. Med Clin Barc. 2004;123(11):433–4. http://dx.doi.org/10.1016/S0025-7753(04)74542-Xspa
dc.relation.referencesGoodman L, Gilman A, Hardman J, Limbird LE. Goodman & Gilman’s The Pharmacological basis of therapeutics. 12th ed. New York: McGraw Hill; 2006.spa
dc.relation.referencesLanas Arbeloa Á. Avances en patología gastrointestinal relacionada con el tratamiento con antiinfl amatorios no esteroideos y antiagregantes plaquetarios. Gastroenterol Hepatol. 2011;34(1):35–42. http://dx.doi.org/10.1016/S0210-5705(11)70005-Xspa
dc.relation.referencesFirth AM, Haldane SL. Development of a scale to evaluate postoperative pain in dogs. JAVMA. 1999;214(5):651–9.spa
dc.relation.referencesGómez LF, Hernánndez CA, Restrepo-Betancurt LF, Orozco S. Comparación de etomidato, ketamina y propofol como inductores para gastroduodenoscopia en perros. Rev Colomb Cienc Pecu. 2007;20(1):59–66.spa
dc.relation.referencesOddone AJ, Rodríguez-Jurado PM. Enfermedades Congénictas y Hereditarias de las Razas Caninas y Felinas. Primera. Buenos Aires: Intermedica; 2010. 147 p.spa
dc.relation.referencesHou Y, Wang Y, Lust G, Zhu L, Zhang Z, Todhunter RJ. Retrospective Analysis for Genetic Improvement of Hip Joints of Cohort Labrador Retrievers in the United States: 1970–2007. PLoS ONE. 2010;5(2):9410. http://dx.doi.org/10.1371/journal.pone.0009410spa
dc.relation.referencesChe Y-F, Jobanputra P, Barton P, Bryan, S, Harris, G, Taylor, RS, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2008;12(1):25–32.spa
dc.relation.referencesLlau JV, De Andrés, J J, Gomar C, Gómez-Luque A, Hidalgo F, Sahagún J, et al. Fármacos que alteran la hemostasia y técnicas regionales anestésicas y analgésicas: recomendaciones de seguridad (foro de consenso). R E V Soc Esp Dolor. 2001;8(1):337–48.spa
dc.relation.referencesCampora C, Freeman KP, Lewis FI, Gibson G, Sacchini F, Sanchez-Vazquez MJ. Determination of haematological reference intervals in healthy adult greyhounds. JSAP. 2011 Jun;52(1):301–9. http://dx.doi.org/10.1111/j.1748-5827.2011.01070.xspa
dc.relation.referencesSteagall, P, Mantovani FB, Ferreira TH, Salcedo E, Mouthi-o FQ, Luna LS. Evaluation of the adverse effects of oral firocoxib in healthy dogs. J Vet Pharmacol Ther. 2007; 30:2218–23. http://dx.doi.org/10.1111/j.1365-2885.2007.00842.xspa
dc.relation.referencesChopra S, Kishore-Saini R, Nath-Sanyal S. Intestinal toxicity of non-steroideal anti-inflammatory drugs with differential cyclooxigenase inhibition selectivity. Nutr Hosp. 2007;22(5):528–37.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistamvz.unicordoba.edu.co/article/view/91spa
dc.subjectDogspa
dc.subjectNSAIDSspa
dc.subjectpainspa
dc.subjectpharmacologyspa
dc.titleAnalgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritisspa
dc.title.translatedAnalgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritiseng
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication
Archivos
Colecciones
HAJ. Revista MVZ